TuesdayMar 20, 2012 12:33 pm

Medisafe 1 Technologies Corp. (MFTH) Offers Solution to Billion Dollar Health Care Problem

Imagine the following scenario: A metropolitan hospital or medical center has two patients with the same or similar names housed in the same room. Although steps are usually taken to avoid things like this, the high volume of patient traffic, together with room shortages, continually changing shifts of support staff, and other factors mean situations like this can and do happen. Later, a nurse that has just started her shift and is unfamiliar with the patients proceeds to administer a scheduled medication to the wrong patient in the room. The medication given reacts with medication the patient is already using,…

Continue Reading

MondayMar 12, 2012 8:27 am

Medisafe 1 Technologies Corp. (MFTH) Expands Product Offerings with Marketing and Distribution Agreement

Medisafe 1 Technologies, a developer of patented technologies that physically prevent unauthorized administration of prescription medications, today announced that the company executed a distribution agreement with Natural Dream Laboratories Company Ltd. (http://www.green-charm.com) to carry a broad array of health related products in Natural Dream’s product line. Natural Dream distributes a robust commercial product line that includes treatments for several health related disorders. The company was founded in 2003, backed by the knowledge of chemists, doctors, pharmacists, and scientists who accumulated more than two decades of experience in research and development. "The signing of this distribution agreement enables Medisafe 1 Technologies…

Continue Reading

FridayMar 09, 2012 5:00 pm

Medisafe 1 Technologies Corp. (MFTH) is “One to Watch”

Medisafe 1 Technologies Corp. is focused on developing and commercializing a proprietary solution that effectively prevents unauthorized administration of a drug or medicinal substance by hypodermic needle. The company’s patented technology is a medical assembly with a locking mechanism designed to protect patients from receiving the wrong medication by requiring positive pre-matching between the substance and its intended patient. According to the Institute of Medicine, medication mistakes are the most common medical errors. In addition to harmful and even deadly consequences to patients, these errors result in a conservatively estimated $3.5 billion of additional medical costs for treating drug-related injuries.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered